A detailed history of Raymond James & Associates transactions in Teladoc Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 32,780 shares of TDOC stock, worth $312,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,780
Previous 38,241 14.28%
Holding current value
$312,393
Previous $373,000 19.57%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$6.79 - $10.09 $37,080 - $55,101
-5,461 Reduced 14.28%
32,780 $300,000
Q2 2024

Jul 19, 2024

SELL
$9.65 - $15.06 $30,050 - $46,896
-3,114 Reduced 7.53%
38,241 $373,000
Q1 2024

Apr 22, 2024

SELL
$14.39 - $22.03 $1.93 Million - $2.96 Million
-134,255 Reduced 76.45%
41,355 $624,000
Q4 2023

Jan 16, 2024

SELL
$15.57 - $22.1 $819,417 - $1.16 Million
-52,628 Reduced 23.06%
175,610 $3.78 Million
Q3 2023

Oct 24, 2023

BUY
$18.53 - $29.77 $37,597 - $60,403
2,029 Added 0.9%
228,238 $4.24 Million
Q2 2023

Jul 25, 2023

BUY
$22.42 - $28.17 $154,854 - $194,570
6,907 Added 3.15%
226,209 $5.73 Million
Q1 2023

Apr 14, 2023

BUY
$22.27 - $33.2 $265,592 - $395,943
11,926 Added 5.75%
219,302 $5.68 Million
Q4 2022

Feb 08, 2023

SELL
$22.83 - $33.31 $368,156 - $537,157
-16,126 Reduced 7.22%
207,376 $4.9 Million
Q3 2022

Oct 25, 2022

BUY
$25.35 - $43.66 $10,951 - $18,861
432 Added 0.19%
223,502 $5.67 Million
Q2 2022

Aug 12, 2022

SELL
$28.63 - $75.86 $347,167 - $919,878
-12,126 Reduced 5.16%
223,070 $7.41 Million
Q1 2022

May 11, 2022

BUY
$50.79 - $95.08 $661,184 - $1.24 Million
13,018 Added 5.86%
235,196 $17 Million
Q4 2021

Feb 08, 2022

SELL
$87.43 - $154.29 $1.94 Million - $3.43 Million
-22,241 Reduced 9.1%
222,178 $20.4 Million
Q3 2021

Nov 02, 2021

SELL
$125.92 - $164.64 $635,770 - $831,267
-5,049 Reduced 2.02%
244,419 $31 Million
Q2 2021

Aug 11, 2021

SELL
$132.71 - $192.38 $1.59 Million - $2.31 Million
-12,009 Reduced 4.59%
249,468 $41.5 Million
Q1 2021

May 14, 2021

SELL
$171.3 - $294.54 $3.72 Million - $6.4 Million
-21,727 Reduced 7.67%
261,477 $47.5 Million
Q4 2020

Feb 12, 2021

BUY
$172.44 - $231.8 $238,829 - $321,043
1,385 Added 0.49%
283,204 $56.6 Million
Q3 2020

Nov 04, 2020

BUY
$183.75 - $249.42 $4.23 Million - $5.74 Million
22,996 Added 8.88%
281,819 $61.8 Million
Q2 2020

Jul 28, 2020

BUY
$139.1 - $204.94 $2.32 Million - $3.42 Million
16,711 Added 6.9%
258,823 $49.4 Million
Q1 2020

Apr 21, 2020

SELL
$82.96 - $167.44 $39,986 - $80,706
-482 Reduced 0.2%
242,112 $37.5 Million
Q4 2019

Feb 12, 2020

SELL
$61.54 - $85.88 $307,269 - $428,798
-4,993 Reduced 2.02%
242,594 $20.3 Million
Q3 2019

Nov 07, 2019

BUY
$55.3 - $72.2 $651,268 - $850,299
11,777 Added 4.99%
247,587 $16.8 Million
Q2 2019

Aug 06, 2019

BUY
$49.86 - $66.41 $1.1 Million - $1.47 Million
22,078 Added 10.33%
235,810 $15.7 Million
Q1 2019

May 06, 2019

BUY
$46.23 - $69.99 $1.38 Million - $2.08 Million
29,746 Added 16.17%
213,732 $11.9 Million
Q4 2018

Feb 11, 2019

SELL
$42.88 - $83.72 $1.43 Million - $2.79 Million
-33,291 Reduced 15.32%
183,986 $9.12 Million
Q3 2018

Nov 14, 2018

SELL
$59.4 - $86.35 $650,786 - $946,050
-10,956 Reduced 4.8%
217,277 $18.8 Million
Q2 2018

Aug 14, 2018

BUY
$38.5 - $62.35 $222,414 - $360,195
5,777 Added 2.6%
228,233 $13.2 Million
Q1 2018

May 14, 2018

BUY
$31.3 - $44.05 $3.34 Million - $4.7 Million
106,743 Added 92.25%
222,456 $8.97 Million
Q4 2017

Feb 14, 2018

BUY
$28.05 - $37.1 $100,671 - $133,151
3,589 Added 3.2%
115,713 $4.03 Million
Q3 2017

Nov 13, 2017

BUY
$28.95 - $37.0 $1.52 Million - $1.94 Million
52,507 Added 88.07%
112,124 $3.72 Million
Q2 2017

Aug 14, 2017

BUY
N/A
59,617
59,617 $2.07 Million

Others Institutions Holding TDOC

About Teladoc Health, Inc.


  • Ticker TDOC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 162,196,000
  • Market Cap $1.55B
  • Description
  • Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health cond...
More about TDOC
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.